98%
921
2 minutes
20
Objective: This study employed a biopsychosocial framework to develop structural equation models(SEM)quantifying the multidimensional impact of pain on quality of life in cancer patients, aiming to provide scientific evidence and novel clinical perspectives for evidence-based pain management strategies.
Methods: This cross-sectional study recruited participants experiencing chronic cancer-related pain using convenience sampling from a tertiary cancer hospital in Shandong Province, China, between January and February 2024. Data collection involved face-to-face administration of the Brief Pain Inventory-Short Form and the Quality of Life Questionnaire-Function 17. Descriptive statistics and reliability analyses (Cronbach's α) were performed using SPSS 27.0. Confirmatory factor analysis and SEM were subsequently conducted using AMOS 23.0, with parameters estimated via the maximum likelihood method.
Results: Two SEMs were developed to elucidate relationships between cancer pain and quality of life. The first-phase SEM demonstrated acceptable fit (χ/df= 2.653, GFI = 0.826, RMSEA = 0.078, TLI = 0.902, CFI = 0.916), with all indices meeting established thresholds without modification. In this model, pain intensity significantly impaired cognitive function (B = 0.165, P < 0.001) but showed no significant associations with other quality-of-life domains. Pain interference with activity substantially compromised physical (B = 0.576), role (B = 0.585), cognitive (B = 0.273), and social functioning (B = 0.260), all P < 0.001. While pain interference with affectivity improved physical (B = -0.467) and role functioning (B = -0.455), both P < 0.001. The refined second-phase SEM exhibited improved fit (χ/df= 2.691, GFI = 0.826, RMSEA = 0.078, TLI = 0.900, CFI = 0.912) after modification. In this model, pain significantly impaired cross-domain quality of life: physical function (B = 0.480), role function (B = 0.540), emotional function (B = 0.195), cognitive function (B = 0.715), and social function (B = 0.369), all P < 0.001.
Conclusion: Pain has a negative impact on all aspects of quality of life, and different dimensions of pain interference have varying effects on the dimensions of quality of life. These insights advocate for a multidimensional approach to pain management in cancer care to improve patient quality of life.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12211190 | PMC |
http://dx.doi.org/10.1186/s12885-025-14473-6 | DOI Listing |
Curr Opin Ophthalmol
September 2025
Singapore Eye Research Institute, Singapore National Eye Centre.
Purpose Of Review: Modern presbyopia-correcting intraocular lenses (IOLs) offer a potential solution to address the rising postoperative demand and expectations for spectacle independence following cataract surgery. However, IOL calculation and selection becomes more complex when presented with previous corneal refractive surgery (CRS) or co-existing corneal conditions. This review explores the use of presbyopia-correcting IOLs in eyes with co-existing corneal conditions or surgically altered corneas.
View Article and Find Full Text PDFEur J Heart Fail
September 2025
Cardiology Department, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Aims: There is a lack of data from randomized clinical trials comparing treatment outcomes between conduction system pacing (CSP) modalities and biventricular pacing (BVP) in symptomatic patients with refractory atrial fibrillation (AF) scheduled for atrioventricular node ablation (AVNA). The CONDUCT-AF investigates whether CSP is non-inferior to BVP in improving left ventricular ejection fraction (LVEF) and clinical outcomes in heart failure (HF) patients with symptomatic AF undergoing AVNA.
Methods: This study is an investigator-initiated, prospective, randomized, multicentre clinical trial conducted across 10 European centres, enrolling 82 patients with symptomatic AF, HF with reduced LVEF, and narrow QRS.
JMIR Res Protoc
September 2025
Department of Health Services Research & Administration, College of Public Health, University of Nebraska Medical Center, Omaha, NE, United States.
Background: With the availability of more advanced and effective treatments, life expectancy has improved among patients with metastatic breast cancer (MBC), but this makes communication with their medical oncologist more complex. Some patients struggle to learn about their therapeutic options and to understand and articulate their preferences. Mobile health (mHealth) apps can enhance patient-provider communication, playing a crucial role in the diagnosis, treatment, quality of life, and outcomes for patients living with MBC.
View Article and Find Full Text PDFJMIR Res Protoc
September 2025
Department of Food Science and Technology, Kaunas University of Technology, Kaunas, Lithuania.
Background: Fermented foods vary significantly by food substrate and regional consumption patterns. Although they are consumed worldwide, their intake and potential health benefits remain understudied. Europe, in particular, lacks specific consumption recommendations for most fermented foods.
View Article and Find Full Text PDFJAMA Intern Med
September 2025
Bayer CC AG, Basel, Switzerland.
Importance: There is an unmet need for long-term, safe, effective, and hormone-free treatments for menopausal symptoms, including vasomotor symptoms (VMS) and sleep disturbances.
Objective: To evaluate the 52-week efficacy and safety of elinzanetant, a dual neurokinin-targeted therapy, for treating moderate to severe VMS associated with menopause.
Design, Setting, And Participants: OASIS-3 was a double-blind, placebo-controlled, randomized phase 3 clinical trial that was conducted at 83 sites in North America and Europe from August 27, 2021, to February 12, 2024, and included postmenopausal women aged 40 to 65 years who were seeking treatment for moderate to severe VMS (no requirement for a minimum number of VMS events per week).